Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Proteasome regulation of ULBP1 transcription.

Butler JE, Moore MB, Presnell SR, Chan HW, Chalupny NJ, Lutz CT.

J Immunol. 2009 May 15;182(10):6600-9. doi: 10.4049/jimmunol.0801214.

2.

Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.

Chalupny NJ, Rein-Weston A, Dosch S, Cosman D.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):175-81. Epub 2006 May 24.

PMID:
16750166
3.

ULBPs, human ligands of the NKG2D receptor, stimulate tumor immunity with enhancement by IL-15.

Sutherland CL, Rabinovich B, Chalupny NJ, Brawand P, Miller R, Cosman D.

Blood. 2006 Aug 15;108(4):1313-9. Epub 2006 Apr 18.

4.

Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.

Eleme K, Taner SB, Onfelt B, Collinson LM, McCann FE, Chalupny NJ, Cosman D, Hopkins C, Magee AI, Davis DM.

J Exp Med. 2004 Apr 5;199(7):1005-10. Epub 2004 Mar 29.

5.

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.

Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D.

J Exp Med. 2003 Jun 2;197(11):1427-39.

6.

ULBP4 is a novel ligand for human NKG2D.

Chalupny NJ, Sutherland CL, Lawrence WA, Rein-Weston A, Cosman D.

Biochem Biophys Res Commun. 2003 May 23;305(1):129-35.

PMID:
12732206
7.

Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.

Wu J, Chalupny NJ, Manley TJ, Riddell SR, Cosman D, Spies T.

J Immunol. 2003 Apr 15;170(8):4196-200.

8.

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.

Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M, Cosman D.

J Immunol. 2002 Jan 15;168(2):671-9.

9.

The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions.

Sutherland CL, Chalupny NJ, Cosman D.

Immunol Rev. 2001 Jun;181:185-92. Review.

PMID:
11513139
10.

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.

Cosman D, Müllberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ.

Immunity. 2001 Feb;14(2):123-33.

11.

Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB.

Loo DT, Chalupny NJ, Bajorath J, Shuford WW, Mittler RS, Aruffo A.

J Biol Chem. 1997 Mar 7;272(10):6448-56.

12.

Cell cycle control of T cell apoptosis induced by activation through the T cell antigen receptor.

Chalupny NJ, Zhu L, Yu XZ, Anasetti C.

Adv Exp Med Biol. 1996;406:57-67. Review. No abstract available.

PMID:
8910671
13.

Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.

Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA.

Eur J Immunol. 1995 Oct;25(10):2978-84.

PMID:
7589101
14.

Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis.

Bajorath J, Marken JS, Chalupny NJ, Spoon TL, Siadak AW, Gordon M, Noelle RJ, Hollenbaugh D, Aruffo A.

Biochemistry. 1995 Aug 8;34(31):9884-92.

PMID:
7543281
15.

Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction.

Bajorath J, Chalupny NJ, Marken JS, Siadak AW, Skonier J, Gordon M, Hollenbaugh D, Noelle RJ, Ochs HD, Aruffo A.

Biochemistry. 1995 Feb 14;34(6):1833-44.

PMID:
7531493
16.

Tyrosine phosphorylation of CD19 in pre-B and mature B cells.

Chalupny NJ, Kanner SB, Schieven GL, Wee SF, Gilliland LK, Aruffo A, Ledbetter JA.

EMBO J. 1993 Jul;12(7):2691-6.

17.

The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A.

EMBO J. 1992 Dec;11(12):4313-21.

18.

T-cell activation molecule 4-1BB binds to extracellular matrix proteins.

Chalupny NJ, Peach R, Hollenbaugh D, Ledbetter JA, Farr AG, Aruffo A.

Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10360-4.

19.

Recombinant globulins: novel research tools and possible pharmaceuticals.

Hollenbaugh D, Chalupny NJ, Aruffo A.

Curr Opin Immunol. 1992 Apr;4(2):216-9. Review.

PMID:
1605911
20.

Association of CD8 with p56lck is required for early T cell signalling events.

Chalupny NJ, Ledbetter JA, Kavathas P.

EMBO J. 1991 May;10(5):1201-7.

Supplemental Content

Loading ...
Support Center